EVALUATION OF DOSE-REPONSE RELATIONS IN CASE-CROSSOVER STUDIES

被引：0
|
作者：
MITTLEMAN, MA [1 ]
MACLURE, M [1 ]
机构：
[1] HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 1994年 / 139卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] Case-crossover studies
    Künzli, N
    Schindler, C
    EPIDEMIOLOGY, 2005, 16 (04) : 592 - 593
  • [2] Case-crossover studies
    Lydersen, Stian
    Bjorngaard, Johan Hakon
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (03)
  • [3] NATURE OF DOSE-REPONSE RELATIONSHIP OF PHOTOTHERAPY FOR NEONATAL HYPERBILIRUBINEMIA
    TAN, KL
    JOURNAL OF PEDIATRICS, 1977, 90 (03): : 448 - 452
  • [4] PHARMACODYNAMICS AND DOSE-REPONSE RELATIONSHIPS OF CILAZAPRIL IN ESSENTIAL-HYPERTENSION
    AJAYI, AA
    ELLIOTT, HL
    MCCULLOCH, J
    HUGHES, DM
    REID, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (01) : P82 - P82
  • [5] Case-crossover studies - The authors respond
    Sullivan, J
    Sheppard, L
    Schreuder, A
    Kaufman, J
    EPIDEMIOLOGY, 2005, 16 (04) : 593 - 593
  • [6] Interpretation and bias in case-crossover studies
    Redelmeier, DA
    Tibshirani, RJ
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (11) : 1281 - 1287
  • [7] Differential misclassification of exposure in case-crossover studies
    Möller, J
    Hessén-Söderman, AC
    Hallqvist, J
    EPIDEMIOLOGY, 2004, 15 (05) : 589 - 596
  • [8] Sample size estimation for case-crossover studies
    Dharmarajan, Sai
    Lee, Joo-Yeon
    Izem, Rima
    STATISTICS IN MEDICINE, 2019, 38 (06) : 956 - 968
  • [9] Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta?
    Checkley, William
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (03) : 242 - 243
  • [10] Permanent User Bias in Case-Crossover Studies in Pharmacoepidemiology
    Hallas, Jesper
    Wang, Shirley V.
    Gagne, Joshua J.
    Schneeweiss, Sebastian
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 1 - 2
12345